Livecareer-Resume
JC
Jessica Claire
Montgomery Street, San Francisco, CA 94105 (555) 432-1000, resumesample@example.com
Professional Summary
Personable Oncology Physician who excels in high-stress environments. Focused on putting patients at ease and clearly diagnosing even the most difficult cases.
Licenses
PhD Clinical Oncology, MSc Clinical Oncology, MBBCh of Medicine and Surgery

Skill Highlights
  • Good bedside manner
  • Quality assurance awareness
  • Decision-making under pressure
  • High ethical standards
  • Collaborative
  • Level-headed
  • Practice-based learning
  • Adult Medical Oncology Consultant
  •  Professor of Oncology
Professional Experience
09/2015 to 03/2016 Professor of Oncology New Mexico State University | Las Cruces, NM, Egypt
Improved performance at the organizational, departmental and individual levels.
Rapidly assessed and responded to medical emergencies.
Specialized in the diagnosis, treatment and management of brain and nervous system disorders.
Discussed various treatment options extensively with patients and families.
05/2008 to 09/2015 Assistant Professor University Of Texas At Austin | Austin, TX, In the Center of Clinical Oncology and Nuclear Medicine (NEMROCK), Faculty of Medicine, Cairo University from June 2008 till October 2015, Egypt.
04/2002 to 06/2008 Lecturer Faculty Of Medicine | City, STATE,
  • In the Center of Clinical Oncology and Nuclear Medicine (NEMROCK), Faculty of Medicine, Cairo University from May 2002 till July 2008, Egypt.
06/1997 to 04/2002 Assistant Lecturer Faculty Of Medicine | City, STATE,
  • In the Center of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Cairo University from July 1997 till May 2002, Egypt.
08/1983 to 08/1986 Oncology Fellow Faculty Of Medicine | City, STATE,
  • Faculty of Medicine, Cairo University from September 1993 to September 1996, Egypt.

Education and Training
Expected in 1991 MBBCh | Medicine and Surgery Kasr El-Aini School of Medicine, Cairo, Kasr El-Aini GPA:
MBBCh of Medicine and Surgery
Expected in 1996 MSc | Oncology Kasr El-Aini School of Medicine, Cairo, Kasr El-Aini GPA:
Master degree in Oncology
Thesis title: "Clinico-epidemiologic study of Colorectal cancer in Egypt" (Retrospective study). *M.B.B.Ch. Faculty of Medicine, Kasr El-Aini, Cairo University in December, 1991 and was signed excellent.
Expected in 2001 Ph.D. | Oncology Kasr El-Aini School of Medicine, Cairo, Kasr El-Aini GPA:
Dectorate in Oncology
Thesis Title: “Comparative Study between Conventional Simulation and CT attached Simulation in Irradiation of Pelvic Malignancies” (Prospective Study).
Expected in In Clinical Oncology (Radiation Therapy and Medical Oncology), Faculty of Medicine, Kasr El-Aini, Cairo University in November, 1996 and was graded good. | , , GPA:
Community Service
Community education for early detection of cancer
Outreach program
Accomplishments
  • National and International publications in the field
  • Skillfully treated high risk cancer patients
Professional Affiliations
American Society of Oncology (ASCO)
European Society of Medical Oncology
Egyptian Medical Syndicate
Egyptian Cancer Society
Saudi Council of Health Specialities (SCHS)
Saudi Cancer Foundation (SCF)
Publications
1. The predictive role of pretreatment 18 F-FDG (PET/CT) maximum standardized uptake value in multiple or oligometastatic breast cancer patients: J Nucl Med Radiat Ther, 2015: Volume 6 • Issue 4 • 1000236 ISSN: 2155-9619 JNMRT, an open access journal. Oral presentation at the RSNA 100th Scientific Assembly and Annual Meeting, November 30 to December 5, 2014 at McCormick Place, Chicago, IL. Public ID: SSK23-02 Time: 3 Dec 2014 10:40 AM.      
2. Correlation of preoperative ki 67 and CA 15.3 levels with the outcome in early breast cancer. A multi institutional study: Poster presentation at 18 th ECCO – 40 th ESMO European cancer congress, Vienna, Austria, 28 septemper 2015 from 9:15 – 11:15.   
3. EGFR Inhibitors in Treatment of Lung Adenocarcinoma: Kasr El-aini J. Clin. Oncol.and nucl. Med, July 2014.   
4. Plasma EBV DNA concentration correlates with FDG PET in Nasopharyngeal carcinoma treated with induction chemotherapy: Poster presentation in ESMO published in Annals of Oncology, volume 23, Sept 2012 Supplement 9.      
5. Epidemiology and Clinical Features of Renal Cell Carcinoma, Experience of Single Institute: Abstract in Best of ASCO held in Cairo, Egypt, 20-21 Sept 2012.     
6. Preoperative Concurrent Chemoradiation for Patients with Rectal cancer, Experience of a Single Institute: Oral presentation in Best of ASCO held in Dammam, KSA, 12-13 Sept 2012.      
7. Survival of patients with locally advanced triple-negative breast cancer after neoadjuvant platinum-containing chemotherapy: Experience of a single institute: Abstract  published in J Clin Oncol 29, 2011 (suppl 27; abstr 274).      
8. Neoadjuvant platinum containing regimen for locally advanced triple negative breast cancer: Abstract  published in ECCO 16 – 35th     ESMO   Congress, Milan 8-12 October 2010.      
9. Clinical and Pathological assessment of response of locally advanced breast Cancer to upfront triplet combination chemotherapy (Docetaxel, Epirubicin and Cyclophosphamide): Phase II Study, BMJ Middle East, Vol 16 No 172 ISSN 1106 5028, June 2009.    
10. HER-2 Positive Locally Advanced Breast Cancer:  One or Two entities? Poster presentation in ECCO 15 – 34th ESMO   Congress 20-24 September, Berlin 2009.      
11. What is the optimal duration of Folfox and Bevacizumab in metastatic Colorectal Cancer, Annals of Oncology, Vol 19, Suppl 3, May 2008.      
12. Clinical and Pathological Assessment of Response of Locally advanced Breast Cancer to Upfront Triplet Combination Chemotherapy (Docetaxel, Epirubicin and Cyclophosphamide): PHASE II STUDY, Kasr El Aini Journal of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Cairo University, May 2008.        
13. Kasr El-Aini Experience in Radiation Safety and Quality Management Program in Intravascular Brachytherapy: Poster presentation in 16th International Conference on Medical Physics (ICMP 2008), Dubai, April 14-16, 2008, UAE.  
14. What is the optimum duration of FOLFOX-Bevacizumab in metastatic colorectal cancer (CRC): Abstract accepted for Poster presentation in 6th International Symposium on Targeted Anticancer Therapies (TAT 2008), Bethesda, MD, March 20-22, 2008, USA.      
15. Neoadjuvant Chemotherapy followed by Concurrent Chemoradiation in treatment of Locally Advanced Nasopharyngeal Cancer, Gulf Journal of Oncology, Issue 3, January 2008.        
16. FOLFOX and Bevacizumab as First Line Treatment in Metastatic Colorectal Cancer: Phase II Study, Kasr El Aini Journal Of Clinical Oncology and Nuclear Medicine, Faculty of Medicine Cairo University, Vol. 3, No. 3-4, July-Oct. 2007.      
17. Liposomal Doxorubicin in Relapsing Ovarian Carcinoma: Phase II Study, Kasr El Aini Journal Of Clinical Oncology and Nuclear Medicine, Faculty of Medicine Cairo University, Vol. 3, No. 3-4, July-Oct. 2007.      
18. Outcome of Ablation of Thyroid Remnants with 100 mCi (3.7 GBq) Iodine-131 in Patients with Thyroid Cancer, Medical Journal of Cairo University, Vol. 75, No. 2, Suppl. June:187-191, 2007.      
19. Quality Management Program for Intra Vascular Brachytherapy: Poster presentation in   Kasr El Aini Conference of Clinical Oncology and Nuclear Medicine (NEMROCK), Cairo University, 1- 4 December 2006.      
20.  Color Doppler Ultrasound as an Objective Assessment Tool for Response to Chemotherapy in Locally Advanced Breast Cancer, Kasr El Aini Journal Of Clinical Oncology and Nuclear Medicine, Faculty of Medicine Cairo University, Vol. 2, No. 3-4, July-Oct. 2006.      
21. Oxaliplatin and Capecitabine in the Treatment of Metastatic Colorectal Cancer (Phase-II Study), Kasr El Aini Journal of Clinical Oncology and Nuclear Medicine, Faculty of Medicine Cairo University, Vol. 2, No. 3-4, July-Oct. 2006.      
22. Primary Combined Chemotherapy in Locally Advanced or Metastatic Parotid Carcinoma , Kasr El Aini Journal Of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Cairo University , Vol 1, No. 2, October 2005 . 23. Role of Gemcitabine, Oxaliplatin and Prednisolone Combination as First Line Chemotherapy in Non-Hodgkin’s Lymphoma , Medical Journal Of Cairo University , Faculty of Medicine, Cairo University, Vol. 73, No. 2,  June 2005.
Interests
Travel, chess and tennis playing
Skills
Communication skills
Computer skills
Publications
Additional Information
  • Teaching young oncologist
  • ​Outreach programs
  • Screening and early detection

By clicking Customize This Resume, you agree to our Terms of Use and Privacy Policy

Disclaimer

Resumes, and other information uploaded or provided by the user, are considered User Content governed by our Terms & Conditions. As such, it is not owned by us, and it is the user who retains ownership over such content.

How this resume score
could be improved?

Many factors go into creating a strong resume. Here are a few tweaks that could improve the score of this resume:

82Good

resume Strength

  • Length
  • Personalization
  • Strong Summary
  • Target Job
  • Typos

Resume Overview

School Attended

  • Kasr El-Aini School of Medicine
  • Kasr El-Aini School of Medicine
  • Kasr El-Aini School of Medicine

Job Titles Held:

  • Professor of Oncology
  • Assistant Professor
  • Lecturer
  • Assistant Lecturer
  • Oncology Fellow

Degrees

  • MBBCh
  • MSc
  • Ph.D.
  • In Clinical Oncology (Radiation Therapy and Medical Oncology), Faculty of Medicine, Kasr El-Aini, Cairo University in November, 1996 and was graded good.

By clicking Customize This Resume, you agree to our Terms of Use and Privacy Policy

*As seen in: